BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005

BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005

No trades
See on Supercharts

BIIB fundamentals

BIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 financial statements, including revenue, expenses, and profit

The total revenue of BIIB for the last quarter is 2.47 T ARS, and it's 5.55% higher compared to the previous quarter. The net income of Q1 25 is 253.86 B ARS.

Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: ARS
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth